Flow Cytometry in Oncology & Immunology Market by Type, Technology, Product & Service, End User - Global Forecast 2025-2030- Product Image

Sale

Flow Cytometry in Oncology & Immunology Market by Type, Technology, Product & Service, End User - Global Forecast 2025-2030

Report
190 Pages
October 2024
Region: Global
360iResearch™
ID: 5924942

UP TO €695EUR$697USD£573GBP OFF until Dec 31^st 2024

The Flow Cytometry in Oncology & Immunology Market grew from USD 1.10 billion in 2023 to USD 1.18 billion in 2024. It is expected to continue growing at a CAGR of 9.33%, reaching USD 2.06 billion by 2030.

Flow cytometry is an advanced biotechnological tool used extensively in oncology and immunology for detailed cell analysis and sorting, offering critical insights into cell populations and their characteristics. Its scope spans diagnostics, therapeutic monitoring, and research and development, leveraging its capacity to analyze physical and chemical properties of thousands of particles per second. The necessity of flow cytometry in these fields is underscored by the surging prevalence of cancer and autoimmune diseases, driving the demand for precision medicine and personalized treatment strategies. Its applications are vast, encompassing cellular analysis in cancer, identifying immune deficiencies, and characterizing cell types in research environments. The end-use scope includes clinical laboratories, research institutions, hospitals, and pharmaceutical companies.

Key growth influencers include technological advancements, such as multi-parametric analysis capabilities, innovation in reagent and software development, and growing investments in biological research. Increasing collaborations between research institutions and biotechnology companies further bolster market growth by streamlining technology transfer and application. Potential opportunities lie in the expansion of point-of-care testing capabilities, miniaturization of devices for enhanced accessibility, and integration of artificial intelligence to improve data interpretation and accuracy. However, market growth faces challenges such as the high cost of instruments, a scarcity of skilled professionals adept in advanced techniques, and stringent regulatory landscapes.

Innovative research can focus on developing cost-effective flow cytometry solutions and creating user-friendly platforms that simplify operation and analysis, broadening adoption in resource-limited settings. Additionally, expanding the application of flow cytometry into emerging fields like organ-on-a-chip technology and exploring its role in novel therapeutic approaches like CAR-T cell therapy can propel market advancements. Overall, the flow cytometry market displays dynamic growth potential, but demands coordinated efforts to navigate its financial and operational barriers, ensuring technological innovations align with market needs.

Understanding Market Dynamics in the Flow Cytometry in Oncology & Immunology Market

The Flow Cytometry in Oncology & Immunology Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.

Market Drivers
- Rising Incidence of cancer and immunological disorders
- Growing development of personalized treatment approaches
- Surging public-private initiatives in the field of immunology and immune-oncology research
Market Restraints
- High Cost of equipment and reagents
Market Opportunities
- Integration with multi-omics approaches in flow cytometry for oncology & immunology
- Miniaturization and advancements in flow cytometry technology
Market Challenges
- Regulatory and compliance issues coupled with technically challenging for identifying and characterizing rare cell

Exploring Porter’s Five Forces for the Flow Cytometry in Oncology & Immunology Market

Porter’s Five Forces framework further strengthens the insights of the Flow Cytometry in Oncology & Immunology Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Flow Cytometry in Oncology & Immunology Market

External macro-environmental factors deeply influence the performance of the Flow Cytometry in Oncology & Immunology Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Flow Cytometry in Oncology & Immunology Market

The Flow Cytometry in Oncology & Immunology Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Flow Cytometry in Oncology & Immunology Market

The Flow Cytometry in Oncology & Immunology Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Flow Cytometry in Oncology & Immunology Market

The Flow Cytometry in Oncology & Immunology Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Flow Cytometry in Oncology & Immunology Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Apogee Flow Systems Ltd., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., bioMérieux SA, Cytek Biosciences, Inc., Enzo Life Sciences, Inc., General Electric Company, GenScript Biotech Corporation, Merck KGaA, Miltenyi Biotec B.V. & CO. KG, Nanocellect Biomedical, Inc., Novozymes A/S, On-Chip Biotechnologies Co., Ltd., RareCyte, Inc., Sartorius AG, Sony Biotechnology Inc., Stratedigm, Inc., Sysmex Corporation, Thermo Fisher Scientific, Inc., and Union Biometrica, Inc..

Market Segmentation & Coverage

This research report categorizes the Flow Cytometry in Oncology & Immunology Market to forecast the revenues and analyze trends in each of the following sub-markets:

Type
- Immunology
- Oncology
Technology
- Bead-based Flow Cytometry
- Cell-based Flow Cytometry
Product & Service
- Accessories
- Flow Cytometry Instruments
  - Cell Analyzers
  - Cell Sorters
- Instruments
- Reagents & Consumables
- Services
- Software
End User
- Academic Research Institutes
- Contract Research Organizations
- Hospitals, Diagnostic Laboratories
- Pharmaceutical & Biotechnology Companies

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

What is the current size of the market, and how is it expected to grow?
Which products, segments, and regions present the most attractive investment opportunities?
What are the prevailing technology trends and regulatory factors influencing the market?
How do top vendors rank regarding market share and competitive positioning?
What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
4. Market Overview

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising Incidence of cancer and immunological disorders
5.1.1.2. Growing development of personalized treatment approaches
5.1.1.3. Surging public-private initiatives in the field of immunology and immune-oncology research
5.1.2. Restraints
5.1.2.1. High Cost of equipment and reagents
5.1.3. Opportunities
5.1.3.1. Integration with multi-omics approaches in flow cytometry for oncology & immunology
5.1.3.2. Miniaturization and advancements in flow cytometry technology
5.1.4. Challenges
5.1.4.1. Regulatory and compliance issues coupled with technically challenging for identifying and characterizing rare cell
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental

6. Flow Cytometry in Oncology & Immunology Market, by Type

6.1. Introduction
6.2. Immunology
6.3. Oncology

7. Flow Cytometry in Oncology & Immunology Market, by Technology

7.1. Introduction
7.2. Bead-based Flow Cytometry
7.3. Cell-based Flow Cytometry

8. Flow Cytometry in Oncology & Immunology Market, by Product & Service

8.1. Introduction
8.2. Accessories
8.3. Flow Cytometry Instruments
8.3.1. Cell Analyzers
8.3.2. Cell Sorters
8.4. Instruments
8.5. Reagents & Consumables
8.6. Services
8.7. Software

9. Flow Cytometry in Oncology & Immunology Market, by End User

9.1. Introduction
9.2. Academic Research Institutes
9.3. Contract Research Organizations
9.4. Hospitals, Diagnostic Laboratories
9.5. Pharmaceutical & Biotechnology Companies

10. Americas Flow Cytometry in Oncology & Immunology Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Flow Cytometry in Oncology & Immunology Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Flow Cytometry in Oncology & Immunology Market

12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape

13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.4. Strategy Analysis & Recommendation

List of Figures

FIGURE 1. FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET RESEARCH PROCESS
FIGURE 2. FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 9. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2030 (%)
FIGURE 11. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 13. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. AMERICAS FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 15. AMERICAS FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. UNITED STATES FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 17. UNITED STATES FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. ASIA-PACIFIC FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. ASIA-PACIFIC FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 23. FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET, FPNV POSITIONING MATRIX, 2023

List of Tables

TABLE 1. FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET DYNAMICS
TABLE 7. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY BEAD-BASED FLOW CYTOMETRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CELL-BASED FLOW CYTOMETRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CELL ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CELL SORTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY HOSPITALS, DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 34. ARGENTINA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 35. ARGENTINA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 36. ARGENTINA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 37. ARGENTINA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 38. ARGENTINA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 39. BRAZIL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 40. BRAZIL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 41. BRAZIL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 42. BRAZIL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 43. BRAZIL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 44. CANADA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 45. CANADA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 46. CANADA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 47. CANADA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 48. CANADA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 49. MEXICO FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 50. MEXICO FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 51. MEXICO FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 52. MEXICO FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 53. MEXICO FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 60. ASIA-PACIFIC FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 61. ASIA-PACIFIC FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 62. ASIA-PACIFIC FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 63. ASIA-PACIFIC FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 64. ASIA-PACIFIC FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 65. ASIA-PACIFIC FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 66. AUSTRALIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 67. AUSTRALIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 68. AUSTRALIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 69. AUSTRALIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 70. AUSTRALIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 71. CHINA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 72. CHINA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 73. CHINA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 74. CHINA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 75. CHINA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 76. INDIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 77. INDIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 78. INDIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 79. INDIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 80. INDIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 81. INDONESIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 82. INDONESIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 83. INDONESIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 84. INDONESIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 85. INDONESIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 86. JAPAN FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 87. JAPAN FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 88. JAPAN FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 89. JAPAN FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 90. JAPAN FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 91. MALAYSIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 92. MALAYSIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 93. MALAYSIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 94. MALAYSIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 95. MALAYSIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 96. PHILIPPINES FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 97. PHILIPPINES FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 98. PHILIPPINES FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 99. PHILIPPINES FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 100. PHILIPPINES FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 101. SINGAPORE FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 102. SINGAPORE FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 103. SINGAPORE FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 104. SINGAPORE FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 105. SINGAPORE FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 106. SOUTH KOREA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 107. SOUTH KOREA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 108. SOUTH KOREA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 109. SOUTH KOREA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 110. SOUTH KOREA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 111. TAIWAN FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 112. TAIWAN FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 113. TAIWAN FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 114. TAIWAN FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 115. TAIWAN FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 116. THAILAND FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 117. THAILAND FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 118. THAILAND FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 119. THAILAND FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 120. THAILAND FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 121. VIETNAM FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 122. VIETNAM FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 123. VIETNAM FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 124. VIETNAM FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 125. VIETNAM FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 132. DENMARK FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 133. DENMARK FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 134. DENMARK FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 135. DENMARK FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 136. DENMARK FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 137. EGYPT FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 138. EGYPT FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 139. EGYPT FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 140. EGYPT FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 141. EGYPT FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 142. FINLAND FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 143. FINLAND FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 144. FINLAND FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 145. FINLAND FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 146. FINLAND FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 147. FRANCE FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 148. FRANCE FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 149. FRANCE FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 150. FRANCE FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 151. FRANCE FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 152. GERMANY FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 153. GERMANY FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 154. GERMANY FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 155. GERMANY FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 156. GERMANY FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 157. ISRAEL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 158. ISRAEL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 159. ISRAEL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 160. ISRAEL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 161. ISRAEL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 162. ITALY FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 163. ITALY FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 164. ITALY FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 165. ITALY FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 166. ITALY FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 167. NETHERLANDS FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 168. NETHERLANDS FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 169. NETHERLANDS FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 170. NETHERLANDS FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 171. NETHERLANDS FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 172. NIGERIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 173. NIGERIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 174. NIGERIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 175. NIGERIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 176. NIGERIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 177. NORWAY FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 178. NORWAY FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 179. NORWAY FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 180. NORWAY FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 181. NORWAY FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 182. POLAND FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 183. POLAND FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 184. POLAND FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 185. POLAND FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 186. POLAND FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 187. QATAR FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 188. QATAR FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 189. QATAR FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 190. QATAR FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 191. QATAR FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 192. RUSSIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 193. RUSSIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 194. RUSSIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 195. RUSSIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 196. RUSSIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 197. SAUDI ARABIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 198. SAUDI ARABIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 199. SAUDI ARABIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 200. SAUDI ARABIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 201. SAUDI ARABIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 202. SOUTH AFRICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 203. SOUTH AFRICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 204. SOUTH AFRICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 205. SOUTH AFRICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 206. SOUTH AFRICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 207. SPAIN FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 208. SPAIN FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 209. SPAIN FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 210. SPAIN FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 211. SPAIN FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 212. SWEDEN FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 213. SWEDEN FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 214. SWEDEN FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 215. SWEDEN FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 216. SWEDEN FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 217. SWITZERLAND FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 218. SWITZERLAND FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 219. SWITZERLAND FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 220. SWITZERLAND FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 221. SWITZERLAND FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 222. TURKEY FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 223. TURKEY FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 224. TURKEY FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 225. TURKEY FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 226. TURKEY FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 230. UNITED ARAB EMIRATES FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 231. UNITED ARAB EMIRATES FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 232. UNITED KINGDOM FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 234. UNITED KINGDOM FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 236. UNITED KINGDOM FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 237. FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SHARE, BY KEY PLAYER, 2023
TABLE 238. FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Flow Cytometry in Oncology & Immunology Market, which are profiled in this report, include:

Agilent Technologies, Inc.
Apogee Flow Systems Ltd.
Becton, Dickinson and Company
Bio-Rad Laboratories, Inc.
bioMérieux SA
Cytek Biosciences, Inc.
Enzo Life Sciences, Inc.
General Electric Company
GenScript Biotech Corporation
Merck KGaA
Miltenyi Biotec B.V. & CO. KG
Nanocellect Biomedical, Inc.
Novozymes A/S
On-Chip Biotechnologies Co., Ltd.
RareCyte, Inc.
Sartorius AG
Sony Biotechnology Inc.
Stratedigm, Inc.
Sysmex Corporation
Thermo Fisher Scientific, Inc.
Union Biometrica, Inc.

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	190
Published	October 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 1.18 Billion
Forecasted Market Value ( USD ) by 2030	$ 2.06 Billion
Compound Annual Growth Rate	9.3%
Regions Covered	Global
No. of Companies Mentioned	21

License	Format	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access		This is a single user license, allowing one user access to the product.	€3535EUR$3,545USD£2,916GBP €3928EUR$3,939USD£3,239GBP
ENTERPRISE LICENSE PDF, Excel and Online Access		This is an enterprise license, allowing all employees within your organization access to the product.	€6255EUR$6,272USD£5,158GBP €6950EUR$6,969USD£5,731GBP

Understanding Market Dynamics in the Flow Cytometry in Oncology & Immunology Market

Exploring Porter’s Five Forces for the Flow Cytometry in Oncology & Immunology Market

Applying PESTLE Analysis to the Flow Cytometry in Oncology & Immunology Market

Analyzing Market Share in the Flow Cytometry in Oncology & Immunology Market

Evaluating Vendor Success with the FPNV Positioning Matrix in the Flow Cytometry in Oncology & Immunology Market

Strategic Recommendations for Success in the Flow Cytometry in Oncology & Immunology Market

Key Company Profiles

Market Segmentation & Coverage

The report provides a detailed overview of the market, exploring several key areas:

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Flow Cytometry in Oncology and Immunology Global Market Report 2024

Flow Cytometry - Market Insights, Competitive Landscape, and Market Forecast - 2030

Flow Cytometry Market Size and Forecasts 2024-2034: Global and Regional Share, Trends, and Growth Opportunity Analysis by Product; Technology; Application; and End-User

Flow Cytometry Market by Technology (Cell-based, Bead-Based), Product & Service (Analyzer, Sorter, Consumables (Antibodies, Assays, Kits), Software), Application (Research (Immunology, Stem Cell, Apoptosis), Clinical (Cancer)) - Forecast to 2032

Flow Cytometry Market Report by Product and Service, Technology, Application, End-User, and Region 2024-2032